- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03609749
Mindful Self-Regulation fMRI Study (MindfulPCfMRI)
November 11, 2020 updated by: Cambridge Health Alliance
Mindfulness Influences on Self-Regulation: Mindful Self-Regulation fMRI Study
The purpose of this study is to investigate changes in functional neural activation during self-regulation tasks before compared to after the Mindfulness Training for Primary Care intervention (see MINDFUL-PC (Phase 3) clinical trial).
The study will also look at whether chronic disease self-management action plan initiation and successful engagement of self-report and behavioral self-regulation targets relates to the observed brain activation changes after compared to before the mindfulness intervention.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The investigators will investigate the effects of MTPC on pre/post changes in neural function with self-regulation target engagement, using self-appraisal, cuff pain and pain anticipation, and interoceptive attention fMRI tasks among primary care patients with an anxiety or depressive disorder.
Primary outcome for this study is evaluating the changes in OFC activation during self-criticism blocks within a self-appraisal fMRI task.
Secondary outcomes include changes in activation during self-appraisal fMRI task, pain regulation task, and interoceptive attention task, and the relationship of these targets with medical regimen adherence.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Somerville, Massachusetts, United States, 02143
- Cambridge Health Alliance Center for Mindfulness and Compassion
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
(In addition to all of the inclusion criteria for the main study, see MINDFUL-PC: Integrating Mindfulness into the Patient-Centered Medical Home (Phase 3))
- Adults 21-60 years old enrolled for participation in the MINDFUL-PC study.
- During baseline visit, patient has a history of either major depressive disorder, dysthymia, or generalized anxiety disorder, OR has current mild to moderate symptoms of depression (score range of 10-28 on DASS-21 Depression subscale) or anxiety (score >7 on DASS-21 anxiety subscale).
- Does not have a substance use disorder nor intoxication at the time of scanning. Patients must report no more than infrequent recreational cannabis use (i.e., no more than two times a month) and must report capacity for abstinence from both cannabis and ethyl alcohol for the 72 hours prior to the scan.
- Normal or corrected-to-normal vision, and correction must be with contact lenses.
- Right-handed as defined by Edinburgh Handedness Inventory.
Exclusion Criteria:
- Current severe panic disorder, active severe PTSD symptoms, or psychosis.
- Current suicidality OR severe depression as evidenced by a score of 28 or higher on the DASS-21 Depression subscale.
- Standard direct exclusion criteria for undergoing magnetic resonance imaging (MRI) procedures for research purposes (safety standards), i.e., Meniere's disease, epilepsy, strong claustrophobia, currently pregnant or breastfeeding or planning to conceive or breastfeed during the study, cardiac pacemaker, prosthetic heart valve, neurostimulator, implanted pumps, non-MR-compatible implants or devices.
- A history of neurological disease or injury, including a history of seizures or significant head trauma (i.e., extended loss of consciousness, neurological sequelae, or known structural brain lesion), or previous brain surgery. These participants are excluded because they may confound the results of the study due to potential abnormalities in their nervous system.
- Severe skin disease, skin allergies, or multiple reactions to topical preparations, dressings or tapes (because we will be placing sensors on the skin to record cardiac activity and skin conductance).
- Age greater than 60 years old because age effects may confound the results of the study, because white matter integrity decreases with age and reduced inhibitory control.
- Current meditation or intense yoga practice of more than 10 minutes a day of current mindfulness meditation practice, 200 hours of total lifetime meditation practice (non-MBI), or more than 63 lifetime hours of MBI-related mindfulness practice.
- Participants with body weight >230 lbs or BMI > 38 will require additional in-person screening and PI approval, because of potential tight fit in the MRI scanner.
- Participants with vascular disease, such as peripheral vascular disease, varicose veins, or lymphedema, in both lower limbs.
- Based on clinical judgment and safety assessment by the PI, the participant is inappropriate for fMRI or unable to complete experiments.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness Training for Primary Care
Experimental: Mindfulness Training for Primary Care For intervention description see Mindfulness Training for Primary Care (MTPC) in the study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 3)".
For the Mindfulness Training for Primary Care (MTPC) fMRI - arm, the investigators acquire pre-/post-intervention neuroimaging measures from subjects enrolled in this additional fMRI study.
|
For intervention description see Mindfulness Training for Primary Care (MTPC) in the study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 3)"
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in orbitofrontal cortex activation during the self-criticism condition in self-appraisal task
Time Frame: Weeks 8 - 10
|
This task involves asking the participant to read about situations and imagine him/herself being self-critical or self-reassuring in these conditions.
|
Weeks 8 - 10
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in insula activation during an interoceptive attention task
Time Frame: Weeks 8 - 10
|
This task contrasts an interoceptive attention condition with an exteroceptive attention condition.
|
Weeks 8 - 10
|
Changes in the rostral anterior cingulate cortex and adjacent medial prefrontal cortex (rACC/mPFC) during the anticipation of pain
Time Frame: Weeks 8 - 10
|
This task involves a pressure cuff which is placed on participant's calf and is inflated for periods of 30 seconds to a medium intense pain, as rated by the participants.
|
Weeks 8 - 10
|
Change in activation of the medial prefrontal cortex during the self-criticism condition in self-appraisal task
Time Frame: Weeks 8 - 10
|
This task involves asking the participant to read about situations and imagine him/herself being self-critical or self-reassuring in these conditions.
|
Weeks 8 - 10
|
Correlations between brain activation changes and chronic disease self-management action plan initiation
Time Frame: Weeks 8 - 10
|
Patient self-reported Action Plan Initiation Survey (APIS-5) is a 5-item questionnaire in which patients are asked to list their action plan SMART goal created during the study, and determine whether they met or did not meet the goal using a 7-point Likert scale with scores >=5 representing self-reported initiation of the goal.
|
Weeks 8 - 10
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Longe O, Maratos FA, Gilbert P, Evans G, Volker F, Rockliff H, Rippon G. Having a word with yourself: neural correlates of self-criticism and self-reassurance. Neuroimage. 2010 Jan 15;49(2):1849-56. doi: 10.1016/j.neuroimage.2009.09.019. Epub 2009 Sep 18.
- Farb NA, Segal ZV, Anderson AK. Mindfulness meditation training alters cortical representations of interoceptive attention. Soc Cogn Affect Neurosci. 2013 Jan;8(1):15-26. doi: 10.1093/scan/nss066. Epub 2012 Jun 11.
- Loggia ML, Berna C, Kim J, Cahalan CM, Gollub RL, Wasan AD, Harris RE, Edwards RR, Napadow V. Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia. Arthritis Rheumatol. 2014 Jan;66(1):203-12. doi: 10.1002/art.38191.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 30, 2019
Primary Completion (Actual)
April 1, 2020
Study Completion (Actual)
August 1, 2020
Study Registration Dates
First Submitted
July 25, 2018
First Submitted That Met QC Criteria
July 25, 2018
First Posted (Actual)
August 1, 2018
Study Record Updates
Last Update Posted (Actual)
November 13, 2020
Last Update Submitted That Met QC Criteria
November 11, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHA-IRB-1002/08/14_fMRI
- UH2AT009145 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Mindfulness Training for Primary Care
-
Cambridge Health AllianceNational Center for Complementary and Integrative Health (NCCIH)TerminatedDepression | Anxiety Disorders | Adjustment Disorders | Chronic Illness | Stress Related DisorderUnited States
-
Cambridge Health AllianceBrown University; National Center for Complementary and Integrative Health... and other collaboratorsCompletedDepression | Anxiety | Psychiatric Problem | Neuroimaging | Self-ControlUnited States
-
Cambridge Health AllianceBrown University; National Institutes of Health (NIH); National Center for Complementary... and other collaboratorsCompletedDepression | Anxiety | Adjustment Disorders | Stress Related DisorderUnited States
-
Cambridge Health AllianceNational Center for Complementary and Integrative Health (NCCIH)TerminatedDepression | Anxiety Disorders | Adjustment Disorders | Chronic Illness | Stress Related DisorderUnited States
-
Cambridge Health AllianceThe Arnold P. Gold Foundation; The Arthur Vining Davis FoundationsCompletedDepression | Anxiety | Adjustment Disorder | Stress Related DisorderUnited States
-
Syracuse VA Medical CenterNational Institutes of Health (NIH); National Center for Complementary and...CompletedPost-traumatic Stress DisorderUnited States
-
VA Office of Research and DevelopmentNot yet recruitingDepression | Anxiety | Post Traumatic Stress Disorder (PTSD)United States
-
Syracuse VA Medical CenterSyracuse UniversityCompleted
-
Virginia Commonwealth UniversityAmerican Psychological Association (APA)Completed
-
Bert LeysenIntermutualistic Agency; National Institute for Health and Disability Insurance...CompletedPalliative Care | Primary Health CareBelgium